title: Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients.
authors.forename: Alberto M
authors.initials: AM
authors.lastname: Martelli
authors.forename: Annalisa
authors.initials: A
authors.lastname: Lonetti
authors.forename: Sergio
authors.initials: S
authors.lastname: Amadori
authors.forename: James A
authors.initials: JA
authors.lastname: McCubrey
authors.forename: Francesca
authors.initials: F
authors.lastname: Chiarini
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D058570:TOR Serine-Threonine Kinases
keywords: PI3K/Akt/mTOR; apoptosis; autophagy; cell cycle; combination therapy; leukemia initiating cells; targeted therapy; translation